Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
![Students walking in hallways](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/medium_3/public/2023-07-25-WEB-WEB-WL%20copy.png?itok=PC4tBkA3)
FDA Puts Distributors on Notice for Illegal E-cigarettes Popular with Youth
Distributors are given 15 working days to respond with a corrective action plan.
![Developing FDA CTP's Strategic Plan](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/medium_3/public/ListeningSession_Homepage_0.png?itok=q3SsP2oz)
CTP Listening Session on Strategic Plan Development
CTP will host a virtual listening session on Aug. 22 to obtain input on the development of the 5-year strategic plan, including proposed strategic goals.
![FDA Denies Marketing of myblu Menthol E-Cigarette Product](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/medium_3/public/2023-07-05-WEB-WEB-MDO_0.png?itok=KHwXHv_B)
FDA Denies Marketing of myblu Menthol E-Cigarette Product
The myblu menthol-flavored e-liquid cartridge does not meet the public health standard and the company must stop marketing unauthorized products.
![man in retail vape store talking with customer](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/call_to_action_992x558/public/CTP%20-%20Requirements%20for%20Products%20-%20Vape%20Store.jpg?itok=YlrJDjTI)
Tobacco Product Marketing Granted Orders (MGO)
To date, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products that currently may be lawfully sold in the U.S. The distribution or sale of unlawfully marketed products is subject to enforcement action.
See the Legal E-Cigarette Products to Sell and Other MGOs![CTP - Actions to Address Recommendations from the Reagan-Udall Evaluation of CTP - Main Page](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/call_to_action_992x558/public/CTP%20-%20Actions%20to%20Address%20Recommendations%20from%20the%20Reagan-Udall%20Evaluation%20of%20CTP%20-%20Main%20Page.jpg?itok=VQgY_Lkq)
Actions to Address Recommendations from the Reagan-Udall Foundation Evaluation
At the request of FDA Commissioner Dr. Robert Califf, an independent expert panel facilitated by the Reagan-Udall Foundation (RUF) conducted an operational evaluation of CTP. A final report from the RUF evaluation included 15 recommendations, and in February 2023, CTP published a webpage with detailed plans to address each of the recommendations as quickly as possible. This webpage will be updated routinely to reflect CTP’s latest progress.
Learn About CTP’s Actions to Address the RUF Evaluation![Food and Drug Administration at White Oak](https://public4.pagefreezer.com:443/content/FDA/08-08-2023T13:42/https://www.fda.gov/files/styles/call_to_action_992x558/public/DrupalContactCTPImage.jpg?itok=bfSFaZUJ)
Contact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002